Light Adjustable Lens patient wearing the RxSight UV-protective glasses

RxSight™ 防紫外線保護眼鏡:最佳做法和常見問題

Light Adjustable Lens™ (LAL™) 手術後,你將立即獲得三副 RxSight 防紫外線保護眼鏡,供你在不同環境下佩戴,對眼睛起到保護作用。這類眼鏡為你提供了一層防紫外線 (UV) 光照的保護,以確保你的視力調整的穩定性。Light Adjustable Lens 上有一層名為 ActivShield 的特殊塗層,可提供額外的紫外線防護。

許多患者對這類眼鏡都有疑問,比如「既然晶體已經有紫外線防護功能,為什麼我還需要眼鏡?」以及「戴著眼鏡我還能維持正常的日常活動嗎?」在下文中,你可以找到這些問題和其他問題的答案,還可以深入瞭解使用 RxSight 防紫外線保護眼鏡的更多最佳做法。

RxSight 防紫外線保護眼鏡的工作原理是什麼?

RxSight 防紫外線保護眼鏡的所有鏡架都是由透明的熱塑性聚醯胺材料製成,具有良好的耐熱性和抗紫外線性能。眼鏡配備聚碳酸酯鏡片,這是一種堅固、輕便的塑膠材料,具有很強的抗衝擊性。每副眼鏡都具有相同程度的紫外線防護功能。在最後的鎖定治療之前,應在清醒時佩戴眼鏡。

  • 有色眼鏡:專為白天在戶外佩戴而設計。
  • 透明眼鏡:適用於室內一般活動。
  • 帶有 1.50 D 閱讀附加度數的透明眼鏡:適用於室內近距離工作和閱讀(如需要)。

佩戴 RxSight 防紫外線保護眼鏡時,是否應避免任何特定活動?

雖然 RxSight 防紫外線保護眼鏡能夠提供必要的紫外線防護,但這類眼鏡並不是安全護目鏡,不應該用於滑雪、單板滑雪、游泳、浮潛或彩彈遊戲等高衝擊性活動。請注意你所從事的活動,因為在參加這些活動之前,你可能需要給眼睛更多的時間來恢復。在恢復這些活動之前,請諮詢你的眼科手術護理團隊。

雖然你必須在清醒時佩戴 RxSight 防紫外線保護眼鏡,但睡覺和淋浴時可以摘下眼鏡,除非有陽光直射。

RxSight 防紫外線保護眼鏡有不同的尺寸嗎?

有不同的尺寸可供選擇,以確保佩戴合適。此外,RxSight 防紫外線保護眼鏡還可以根據舒適度進行調整。側臂可以調整,以確保眼鏡牢固地貼合前額和臉頰上部。每副眼鏡都配有掛繩,以防止眼鏡脫落。如果你發現眼鏡需要不同的尺寸或進行調整,請聯絡你的眼科手術護理團隊,探討可用的解決方案。

我可以使用任何阻擋紫外線的眼鏡嗎?

不可以。RxSight 防紫外線保護眼鏡經過嚴格測試,以確保它們能夠為 Light Adjustable Lens 提供必要的保護。RxSight 無法保證其他阻擋紫外線的眼鏡也能提供相同程度的保護。為確保最佳效果,請僅使用你的眼科手術護理團隊提供的眼鏡,並按照說明使用。

RxSight 防紫外線保護眼鏡在你獲得個人化視力的過程中起著至關重要的作用。按照指示佩戴眼鏡,不僅能保護你的視力調整,還能最大限度地發揮 Light Adjustable Lens 的優勢。

如需瞭解更多最佳做法和常見問題,請造訪我們網站上的常見問題頁面

最新文章

白內障手術與乾眼症:須知事項

固定式與可調節型晶體設計:瞭解哪種設計適合你

瞭解白內障手術:讓你的視力從此更清晰

LAL patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).

The Light Adjustable Lens provides optimized vision for patient satisfaction.2

Light Adjustable Lens patients saw nearly as well without glasses (UCDVA) as control patients did with glasses (BCDVA).

Since the Light Adjustable Lens is a monofocal lens, there is low risk of dysphotopsias caused by splitting light, leading to potentially enhanced vision and patient satisfaction.

LAL patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.

The Light Adjustable Lens offers LASIK-like accuracy in cataract surgery.2,3

92% of eyes (N = 391) achieved results within 0.50 D of target manifest refraction spherical equivalent (MRSE).

Patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.

The study was a prospective, controlled, multicenter, 12-month study of 600 patients (ITT population) randomized to receive implantation with the RxSight LAL (N = 403) or a commercially available monofocal IOL (N = 197). Effectiveness analyses included 391 LAL patients and 193 control patients. Primary safety variables included best spectacle-corrected visual acuity (BSCVA) at 6 months and incidence of sight-threatening complications and adverse events. Primary effectiveness variables included percent reduction in manifest cylinder at 6 months, percent mean absolute reduction in MRSE at 6 months, and rotation of meridian of LAL at 6 months. Percent of eyes with an uncorrected visual acuity (UCVA) of 20/20 or better at six months post-operatively compared between the LAL treatment group and the monofocal control group was a secondary endpoint.

The Light Adjustable Lens corrects as low as 0.50 D of astigmatism, which is the lowest level approved to be treated.

The ability to treat 0.50 D of postoperative cylinder makes the Light Adjustable Lens the only IOL in the United States approved to correct this level of vision-altering astigmatism. Astigmatism of as little as 0.50 D can reduce visual acuity by one line, and the impact on dynamic, functional visual acuity and low-contrast acuity is even greater.1